DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. Research Programs
  3. Peer Reviewed Cancer
  4. Topic Areas Offered by Year
  5. FY21 Topic Areas

Peer Reviewed Cancer
FY21 Topic Areas


  • Bladder cancer
  • Blood cancers
  • Brain cancer
  • Cancers associated with the use of beryllium1
  • Colorectal cancer
  • Endometrial cancer
  • Esophageal cancer
  • Germ cell cancers
  • Head and neck cancers
  • Liver cancer
  • Lymphoma
  • Mesothelioma
  • Metastatic cancers2
  • Neuroblastoma
  • Pediatric, adolescent, and young adult cancers3
  • Pediatric brain tumors
  • Stomach cancer
  • Sarcoma
  • Thyroid cancer
  • The link between scleroderma and cancer
1 For “cancers associated with the use of beryllium’ proposed research should target mechanistically the process of cancer risk, initiation, and be agnostic to the cancer type.
2 Metastatic cancer is cancer that has spread from its original location to another place in the body, representing what is known as stage III and stage IV cancer diagnoses.  While recent research has revealed that there is a genetic basis for susceptibility or resistance to metastasis, more research is needed to develop a comprehensive understanding of this complex process.
3 The definition of adolescents and young adults is derived from the National Cancer Institute (https://www.cancer.gov/types/aya).  Research should be targeted toward children (ages 0–14 years), adolescents (ages 15–24 years), and/or young adults (ages 25–39 years).

Congressional language prohibits studies involving breast, kidney, lung, pancreatic, prostate, ovarian, and rare cancers and melanoma to be funded under the PRCRP.

The inclusion of the individual Rare Cancer Research Program shall not prohibit the PRCRP from funding the above mentioned cancers or cancer subtypes that may be rare by definition.

Last updated Thursday, May 26, 2022